Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

556 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Substituting lifestyle management for pharmacological control of blood pressure: a pilot study in Australian general practice.
Reid CM, Maher T, Jennings GL; Heart Project Steering Committee. Reid CM, et al. Among authors: maher t. Blood Press. 2000;9(5):267-74. doi: 10.1080/080370500448650. Blood Press. 2000. PMID: 11193130 Clinical Trial.
Adherence of Irish general practitioners to European guidelines for acute low back pain: a prospective pilot study.
Fullen BM, Maher T, Bury G, Tynan A, Daly LE, Hurley DA. Fullen BM, et al. Among authors: maher t. Eur J Pain. 2007 Aug;11(6):614-23. doi: 10.1016/j.ejpain.2006.09.007. Epub 2006 Nov 27. Eur J Pain. 2007. PMID: 17126046
Preventive health behaviour among general practitioners in Victoria.
McCall L, Maher T, Piterman L. McCall L, et al. Among authors: maher t. Aust Fam Physician. 1999 Aug;28(8):854-7. Aust Fam Physician. 1999. PMID: 10495543
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis.
Kreuter M, Lee JS, Tzouvelekis A, Oldham JM, Molyneaux PL, Weycker D, Atwood M, Kirchgaessler KU, Maher TM. Kreuter M, et al. Among authors: maher tm. Am J Respir Crit Care Med. 2021 Jan 12. doi: 10.1164/rccm.202003-0669OC. Online ahead of print. Am J Respir Crit Care Med. 2021. PMID: 33434107
Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial.
Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, Jouneau S, Michael A, Quaresma M, Rohr KB, Russell AM, Stowasser S, Maher TM; INMARK trial investigators. Noth I, et al. Among authors: maher tm. Eur Respir J. 2021 Jan 8:2001518. doi: 10.1183/13993003.01518-2020. Online ahead of print. Eur Respir J. 2021. PMID: 33419890 Free article.
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial.
Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, Maher TM; SENSCIS trial investigators. Highland KB, et al. Among authors: maher tm. Lancet Respir Med. 2021 Jan;9(1):96-106. doi: 10.1016/S2213-2600(20)30330-1. Lancet Respir Med. 2021. PMID: 33412120
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development.
Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ. Spagnolo P, et al. Among authors: maher tm. Pharmacol Ther. 2020 Dec 24;222:107798. doi: 10.1016/j.pharmthera.2020.107798. Online ahead of print. Pharmacol Ther. 2020. PMID: 33359599 Review.
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression.
Stock CJW, Hoyles RK, Daccord C, Kokosi M, Visca D, De Lauretis A, Alfieri V, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Chua F, Maher TM, Abraham DJ, Ong V, Donovan J, Sestini P, Denton CP, Wells AU, Renzoni EA. Stock CJW, et al. Among authors: maher tm. Respirology. 2020 Dec 17. doi: 10.1111/resp.13988. Online ahead of print. Respirology. 2020. PMID: 33336433
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
Wilson AM, Clark AB, Cahn T, Chilvers ER, Fraser W, Hammond M, Livermore DM, Maher TM, Parfrey H, Swart AM, Stirling S, Thickett DR, Whyte M; EME-TIPAC team. Wilson AM, et al. Among authors: maher tm. JAMA. 2020 Dec 8;324(22):2282-2291. doi: 10.1001/jama.2020.22960. JAMA. 2020. PMID: 33289822 Clinical Trial.
Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations.
Leavy OC, Ma SF, Molyneaux PL, Maher TM, Oldham JM, Flores C, Noth I, Jenkins RG, Dudbridge F, Wain LV, Allen RJ. Leavy OC, et al. Among authors: maher tm. Am J Respir Crit Care Med. 2020 Nov 23. doi: 10.1164/rccm.202008-3211LE. Online ahead of print. Am J Respir Crit Care Med. 2020. PMID: 33226834 No abstract available.
556 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback